Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Leung, Lisa ^a,b   Radulovich, Nikolina ^a,b   Zhu, Chang Qi ^a   Organ, Shawna ^a,b   Bandarchi, Bizhan ^a   Pintilie, Melania ^a   To, Christine ^a   Panchal, Devang ^a   Tsao, Ming Sound ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GEMCITABINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER RESISTANCE; CARCINOGENESIS; CARCINOMA CELL; CELL ADHESION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG SENSITIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR GROWTH; VASCULARIZATION;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOCALINS; MICE; PANCREATIC NEOPLASMS;

EID: 84867131966     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046677     Document Type: Article

References (32)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics. CA Cancer J Clin 5: 277-300.
2. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, et al. (2001) Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 11: 4320-4324.
3. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, et al. (2003) Highly expressed genes in pancreatic ductal adenocarcinomas: A comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 24: 8614-8622.
4. Qian J, Niu J, Li M, Chiao PJ, Tsao MS, (2005) In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Cancer Res 12: 5045-5053.
5. Leng X, Wu Y, Arlinghaus RB, (2011) Relationships of lipocalin 2 with breast tumorigenesis and metastasis. J Cell Physiol 2: 309-314.
6. Goetz DH, Willie ST, Armen RS, Bratt T, Borregaard N, et al. (2000) Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Biochemistry 8: 1935-1941.
7. Chakraborty S, Kaur S, Muddana V, Sharma N, Wittel UA, et al. (2010) Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis. Am J Gastroenterol 9: 2050-2059.
8. Laurell H, Bouisson M, Berthelemy P, Rochaix P, Dejean S, et al. (2006) Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol 21: 3344-3351.
9. Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, et al. (2007) Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 11: 2426-2434.
10. Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, et al. (2008) The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci U S A 37: 14058-14063.
11. Zhang H, Xu L, Xiao D, Xie J, Zeng H, et al. (2007) Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: Significant correlation with cell differentiation and tumour invasion. J Clin Pathol 5: 555-561.
12. Fernandez CA, Yan L, Louis G, Yang J, Kutok JL, et al. (2005) The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 15: 5390-5395.
13. Leng X, Ding T, Lin H, Wang Y, Hu L, et al. (2009) Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res 22: 8579-8584.
14. Berger T, Cheung CC, Elia AJ, Mak TW, (2010) Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis. Proc Natl Acad Sci U S A 7: 2995-3000.
15. Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van Duijn W, et al. (2007) Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer 12: 1869-1876.
16. Playford RJ, Belo A, Poulsom R, Fitzgerald AJ, Harris K, et al. (2006) Effects of mouse and human lipocalin homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin on gastrointestinal mucosal integrity and repair. Gastroenterology 3: 809-817.
17. Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, et al. (2005) Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem J 391: 441-448.
18. Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, et al. (2011) Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci U S A 17: 7160-7165.
19. Radulovich N, Leung L, Tsao MS, (2011) Modified gateway system for double shRNA expression and Cre/lox based gene expression. BMC Biotechnol 11: 24.
20. Navab R, Liu J, Seiden-Long I, Shih W, Li M, et al. (2009) Co-overexpression of met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells. Neoplasia 12: 1292-1300.
21. Hu L, Hittelman W, Lu T, Ji P, Arlinghaus R, et al. (2009) NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Invest 5: 531-548.
22. Yan L, Borregaard N, Kjeldsen L, Moses MA, (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). modulation of MMP-9 activity by NGAL. J Biol Chem 40: 37258-37265.
23. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M, (2011) Pancreatic cancer. Lancet 9791: 607-20.
24. Pham NA, Tsao MS, Cao P, Hedley DW, (2007) Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pancreas 3: e16-26.
25. Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, et al. (2008) Neutrophil gelatinase-associated lipocalin: A novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res 15: 6100-6108.
26. Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, et al. (2009) Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A 10: 3913-3918.
27. Shi H, Gu Y, Yang J, Xu L, Mi W, et al. (2008) Lipocalin 2 promotes lung metastasis of murine breast cancer cells. J Exp Clin Cancer Res 27: 83.
28. Mannelqvist M, Stefansson IM, Wik E, Kusonmano K, Raeder MB, et al. (2012) Lipocalin 2 expression is associated with aggressive features of endometrial cancer. BMC Cancer 1: 169.
29. Tschesche H, Zolzer V, Triebel S, Bartsch S, (2001) The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. Eur J Biochem 7: 1918-1928.
30. Lee HJ, Lee EK, Lee KJ, Hong SW, Yoon Y, et al. (2006) Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer 10: 2490-2497.
31. Venkatesha S, Hanai J, Seth P, Karumanchi SA, Sukhatme VP, (2006) Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells. Mol Cancer Res 11: 821-829.
32. Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, et al. (2008) Early diagnosis of pancreatic cancer: Neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 9: 1540-1547.